Effect of K201, a novel antiarrhythmic drug on calcium handling and arrhythmogenic activity of pulmonary vein cardiomyocytes

YJ Chen, YC Chen, W Wongcharoen… - British journal of …, 2008 - Wiley Online Library
YJ Chen, YC Chen, W Wongcharoen, CI Lin, SA Chen
British journal of pharmacology, 2008Wiley Online Library
Background and purpose: Pulmonary veins are the most important focus for the generation
of atrial fibrillation. Abnormal calcium homeostasis with ryanodine receptor dysfunction may
underlie the arrhythmogenic activity in pulmonary veins. The preferential ryanodine receptor
stabilizer (K201) possesses antiarrhythmic effects through calcium regulation. The purpose
of this study was to investigate the effects of K201 on the arrhythmogenic activity and
calcium regulation of pulmonary vein cardiomyocytes. Experimental approach: The ionic …
Background and purpose
Pulmonary veins are the most important focus for the generation of atrial fibrillation. Abnormal calcium homeostasis with ryanodine receptor dysfunction may underlie the arrhythmogenic activity in pulmonary veins. The preferential ryanodine receptor stabilizer (K201) possesses antiarrhythmic effects through calcium regulation. The purpose of this study was to investigate the effects of K201 on the arrhythmogenic activity and calcium regulation of pulmonary vein cardiomyocytes.
Experimental approach
The ionic currents and intracellular calcium were studied in isolated single cardiomyocytes from rabbit pulmonary vein before and after the administration of K201, by the whole‐cell patch clamp and indo‐1 fluorimetric ratio techniques.
Key results
K201 (0.1, 0.3, 1 μM) reduced the firing rates in pulmonary vein cardiomyocytes, decreased the amplitudes of the delayed afterdepolarizations and prolonged the action potential duration. K201 decreased the L‐type calcium currents, Na+/Ca2+ exchanger currents, transient inward currents and calcium transients. K201 (1 μM, but not 0.1 μM or 0.3 μM) also reduced the sarcoplasmic reticulum calcium content. Moreover, both the pretreatment and administration of K201 (0.3 μM) decreased the isoprenaline (10 nM)‐induced arrhythmogenesis in pulmonary veins.
Conclusions and implications
K201 reduced the arrhythmogenic activity of pulmonary vein cardiomyocytes and attenuated the arrhythmogenicity induced by isoprenaline. These findings may reveal the anti‐arrhythmic potential of K201.
British Journal of Pharmacology (2008) 153, 915–925; doi:10.1038/sj.bjp.0707564; published online 12 November 2007
Wiley Online Library